- Home
- ELTX vs AITR Comparison
ELTX vs AITR Comparison
Compare ELTX & AITR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- AITR
- Stock Information
- Founded
- ELTX 2011
- AITR 2022
- Country
- ELTX United States
- AITR United States
- Employees
- ELTX N/A
- AITR N/A
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- AITR
- Sector
- ELTX Health Care
- AITR
- Exchange
- ELTX Nasdaq
- AITR Nasdaq
- Market Cap
- ELTX 49.7M
- AITR 82.6M
- IPO Year
- ELTX 2021
- AITR 2023
- Fundamental
- Price
- ELTX $4.16
- AITR $10.54
- Analyst Decision
- ELTX Buy
- AITR
- Analyst Count
- ELTX 2
- AITR 0
- Target Price
- ELTX $10.00
- AITR N/A
- AVG Volume (30 Days)
- ELTX 16.1K
- AITR 71.3K
- Earning Date
- ELTX 11-07-2024
- AITR 01-01-0001
- Dividend Yield
- ELTX N/A
- AITR N/A
- EPS Growth
- ELTX N/A
- AITR N/A
- EPS
- ELTX N/A
- AITR N/A
- Revenue
- ELTX N/A
- AITR N/A
- Revenue This Year
- ELTX N/A
- AITR N/A
- Revenue Next Year
- ELTX N/A
- AITR N/A
- P/E Ratio
- ELTX N/A
- AITR N/A
- Revenue Growth
- ELTX N/A
- AITR N/A
- 52 Week Low
- ELTX $2.96
- AITR $10.11
- 52 Week High
- ELTX $11.45
- AITR $10.57
- Technical
- Relative Strength Index (RSI)
- ELTX 40.82
- AITR 78.43
- Support Level
- ELTX $4.05
- AITR $10.51
- Resistance Level
- ELTX $4.89
- AITR $10.57
- Average True Range (ATR)
- ELTX 0.28
- AITR 0.01
- MACD
- ELTX -0.06
- AITR -0.00
- Stochastic Oscillator
- ELTX 27.37
- AITR 83.33
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.
About AITR AI TRANSPORTATION ACQUISITION CORP Ordinary shares
AI Transportation Acquisition Corp is a blank check company.